Medication adherence, healthcare resource utilization, and costs among Medicaid beneficiaries with schizophrenia treated with once-monthly paliperidone palmitate or once-every-three-months paliperidone palmitate
Authors:
- 13 February 2021
- journal article
- research article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 37 (4) , 675-683
Abstract
Antipsychotics with reduced dosing frequency may improve adherence and clinical outcomes for patients with schizophrenia. This study compared treatment patterns, healthcare resource utilization (HR...Keywords
This publication has 22 references indexed in Scilit:
- Humanistic burden in schizophrenia: A literature reviewJournal of Psychiatric Research, 2014
- Long-Acting Injectable Versus Oral Antipsychotics in SchizophreniaThe Journal of Clinical Psychiatry, 2013
- The evidence for illness progression after relapse in schizophreniaSchizophrenia Research, 2013
- Estimating the direct and indirect costs for community-dwelling patients with schizophreniaJournal of Pharmaceutical Health Services Research, 2013
- The nature of relapse in schizophreniaBMC Psychiatry, 2013
- Adherence to Antipsychotics and Cardiometabolic Medication: Association With Health Care Utilization and CostsPsychiatric Services, 2012
- Antipsychotics in the Treatment of SchizophreniaThe Journal of Clinical Psychiatry, 2011
- Adherence to Atypical Antipsychotic Treatment Among Newly Treated PatientsThe Journal of Clinical Psychiatry, 2007
- Partial compliance with antipsychotics and its impact on patient outcomesInternational Journal of Psychiatry in Clinical Practice, 2007
- Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approachPsychological Medicine, 2006